with
joint hypermobility and in 34 - without
hypermobility. Results - There were no significant differences
LIU, Z.,
WANG, X.,
YANG, G.,
ZHONG, C.,
ZHANG, R.,
YE, J.,
ZHONG, Y.,
HU, J.,
OZAL, B.,
ZHAO, S. (2020) be used as drugs for the treatment of GBM. In this study, a multi-database
joint analysis was used